Fenebrutinib helped patients with relapsing forms of MS remain nearly free of relapses and disability progression up to two ...

Alvotech is expanding its partnership with Advanz Pharma to commercialize new products in Europe, including a Kesimpta ...

Pro-inflammatory signaling molecules in MS cause problems with the growth and development of myelin-making cells in the brain ...

Columnist Desiree Lama writes in praise of community and human connections, which make such a difference when living with ...

Children with pediatric-onset MS tend to use more healthcare resources, starting from birth and escalating until their ...

Using disease-modifying therapies in MS tends to reduce the risk of stroke, though effects vary depending on the type of DMT, ...

As aging has her experiencing estrogen loss and her MS, columnist Susan Payrovi evaluates her response to the changes she's ...

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...

While there was more risk, most studies couldn't disentangle the effects of childhood adversity from other factors that may ...

The Epstein-Barr virus — a well-established risk factor for MS — is able to alter the movements of immune cells, a new study ...

Until her daughter left for college, columnist Leigh Anne Nelson didn't realize all the help she was getting. Now she knows.

Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting vs. progressive forms of MS, a ...